Bone Grafts And Substitutes Market Is Expected To Reach US$ 4.44 Bn By 2028

As per industry analysis on bone grafts and substitutes by Fact.MR, a market research and competitive intelligence provider, the global market is anticipated to expand at a CAGR of 4.9% over the forecast period of 2021-2028, reaching US$ 4.44 Bn.

Bone grafting is a surgical operation that uses bone grafts or substitutes to reconstruct a misplaced bone in order to treat bone fractures that pose a serious health risk to the patient. Compound fractures are treated with bone grafting, which is commonly employed in spinal fusion procedures.

Download FREE Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7229

Bone grafts can be used to treat spinal fractures, anchor a repaired spinal deformity, and prevent mobility between two or more vertebral bodies. The bone graft does not immediately fuse or mend the spine, but it does provide a scaffold or foundation for the patient's body to create new bone.

Bone graft and substitute manufacturers are focused on innovative techniques such as fast prototyping and 3D printing, which are also assisting in the manufacturing of free-form biomaterial scaffolds for tissue regeneration.

Growing prevalence of musculoskeletal disorders, advancements in biocompatible synthetic bone grafts, and increase in demand for dental bone grafts are all driving the global bone grafts and substitutes market forward.

The bone grafts and substitutes market in China is growing due to an increase in the usage of allografts and other alternative products, a steady supply of orthopedic equipment, and a growing acceptance of autograft bone.

Owing to the increasing number of patients who rely on medical settings for crucial orthopedic treatments such as spinal fusion, regenerative therapies, and joint reconstruction surgeries, hospitals are expected to be the most dominating section of the global market during the projection period.

Competitive Landscape

Manufacturers of bone grafts and substitutes are constantly investing in the development of new products with improved bioactivity, biocompatibility, and mechanical qualities. Companies have a varied product portfolio that is technologically advanced, as well as a larger global presence. Key players are constantly launching innovative products in various orthopedic application areas.

For instance,

The chronOS Strip bone graft substitute is made by Synthes, Inc., a Johnson & Johnson company. The chronOS-tricalcium phosphate granules in this synthetic bone transplant can be perfused with the patient's bone marrow and blood.

Get Customization on this Report: https://www.factmr.com/connectus/sample?flag=RC&rep_id=7229

Key Takeaways from Market Study

• Global bone grafts and substitutes market to reach a valuation of US$ 4.44 Bn by 2028.
• Market in North America holds a high share of 53.1%.
• Demand for allografts are expected to increase at a significant CAGR over the coming years.

"Rising initiatives to improve the bioactivity of bone graft substitutes, growing adoption of minimally-invasive procedures, and increasing knowledge among patients about biologic bone regeneration benefits are aspects driving market expansion," says a Fact.MR analyst

Winning Strategy

The market is characterized by fierce competition and is dominated by a few important players. To increase revenue, key businesses are focusing on executing creative tactics such as mergers & acquisitions, market penetration, collaborations, and distribution agreements.

Key players in the market are concentrating on diversifying their product portfolios and utilizing materials with higher quality, characteristics, and functionalities.

To understand how our report can bring difference to your business strategy, Purchase a copy of Synthetic Bone Grafts Demand report at

Get Full Access of Complete Report: https://www.factmr.com/checkout/7229

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the global bone grafts and substitutes market, presenting historical demand data (2017-2020) and forecast statistics for the period of 2021-2028.

The study divulges essential insights on the market on the basis of product (allografts, synthetic bone grafts, and others), by material (ceramic-based, polymer-based, growth factor-based, cell-based, and others) by end user (hospitals, orthopedic clinics, and others), across five major regions (North America, Europe, Asia Pacific, Latin America, and MEA).

Check out more related studies published by Fact.MR Research: https://www.globenewswire.com/news-release/2022/10/03/2526452/0/en/Sales-of-Laparotomy-Sponges-Are-Projected-to-Reach-a-Market-Size-of-US-1-6-billion-By-2027-Radiopaque-Laparotomy-Sponges-Widely-Used-in-Thoracic-Surgical-Procedures-Report-Fact-MR.html

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.